Profile data is unavailable for this security.
About the company
JBM (Healthcare) Ltd is an investment holding company principally engaged in the development, manufacture and distribution of Chinese medicines. The Company operates its business through three segments. The Branded Medicines segment is engaged in the development, manufacture and distribution of branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment is engaged in the development, manufacture and distribution of registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal or mineral origin customarily or widely used by the Chinese. The Health and Wellness Products segment is engaged in the distribution and sale of supplements, medical consumables and other nonpharmaceutical products for the general health and wellness of consumers.
- Revenue in HKD (TTM)812.98m
- Net income in HKD216.39m
- Incorporated2020
- Employees412.00
- LocationJBM (Healthcare) LtdUnit 2303-07, 23/F, Tower 1, Millennium388 Kwun Tong Road, Kwun Tong, KowloonKOWLOON Hong KongHKG
- Phone+852 22672178
- Websitehttps://www.jbmhealthcare.com.hk/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 1.05bn | 206.93m | 1.15bn | 798.00 | 5.58 | 0.589 | 4.80 | 1.10 | 0.3694 | 0.3694 | 1.87 | 3.50 | 0.3698 | 2.30 | 3.34 | 1,407,136.00 | 7.30 | 7.46 | 10.54 | 10.45 | 78.95 | 77.80 | 19.74 | 20.45 | 1.42 | -- | 0.0422 | 44.00 | 4.71 | 6.41 | 24.32 | 4.95 | -8.31 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 1.35bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.26bn | 199.57m | 1.77bn | 1.12k | 8.90 | 0.4748 | 6.00 | 1.41 | 0.1326 | 0.1326 | 0.8359 | 2.49 | 0.2809 | 2.47 | 7.96 | 1,064,304.00 | 4.36 | 10.98 | 5.07 | 13.75 | 45.76 | 55.52 | 15.53 | 32.76 | 4.21 | -- | 0.0028 | 31.01 | -7.89 | 2.22 | 73.29 | 17.20 | 17.13 | 2.69 |
| Cutia Therapeutics | 283.11m | -534.12m | 1.83bn | 298.00 | -- | 1.89 | -- | 6.47 | -1.70 | -1.70 | 0.901 | 2.67 | 0.1908 | 2.55 | 5.57 | 850,183.20 | -36.00 | -- | -44.42 | -- | 34.92 | -- | -188.66 | -- | 2.92 | -- | 0.2774 | -- | 103.17 | -- | 77.91 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 39.99m | -314.76m | 1.90bn | 270.00 | -- | 0.9794 | -- | 47.41 | -0.5689 | -0.5689 | 0.0724 | 3.53 | 0.0159 | 1.38 | 9.25 | 136,014.20 | -12.50 | -38.02 | -14.65 | -41.79 | 49.28 | -- | -787.13 | -4,412.89 | 4.36 | -29.83 | 0.1373 | -- | 269.73 | -- | 38.32 | -- | 18.80 | -- |
| Jbm (Healthcare) Ltd | 812.98m | 216.39m | 2.24bn | 412.00 | 10.24 | 2.08 | 8.06 | 2.75 | 0.2657 | 0.2657 | 0.9984 | 1.31 | 0.5111 | 3.76 | 5.05 | 2,913,918.00 | 14.09 | 6.57 | 17.00 | 7.83 | 56.76 | 47.82 | 27.56 | 16.60 | 2.41 | -- | 0.2486 | 53.40 | 20.65 | 15.44 | 51.20 | 36.90 | 35.96 | -- |
| Golden Throat Holdings Group Co Ltd | 1.11bn | 303.22m | 2.34bn | 842.00 | 7.70 | 1.71 | 6.85 | 2.11 | 0.4101 | 0.4101 | 1.50 | 1.85 | 0.467 | 2.29 | 5.32 | 1,267,739.00 | 12.78 | 11.71 | 21.02 | 16.75 | 76.42 | 73.08 | 27.37 | 25.87 | 1.73 | 21.95 | 0.3616 | 94.67 | 23.26 | 8.25 | 27.37 | 13.71 | -12.27 | 34.38 |
| Hangzhou Jiuyuan Genetic Biopharm Co Ltd | 1.48bn | 139.59m | 2.35bn | 1.63k | 15.06 | 1.32 | 12.62 | 1.59 | 0.6462 | 0.6462 | 7.23 | 7.36 | 0.7509 | 1.55 | 2.17 | 958,190.90 | 7.10 | -- | 8.88 | -- | 81.67 | -- | 9.45 | -- | 4.03 | 46.31 | 0.1058 | -- | 6.35 | -- | 15.72 | -- | -- | -- |
| SinoMab Bioscience Ltd | 0.00 | -163.24m | 2.48bn | 61.00 | -- | 7.84 | -- | -- | -0.1508 | -0.1508 | 0.00 | 0.2284 | 0.00 | -- | -- | 0.00 | -18.46 | -22.26 | -24.62 | -25.68 | -- | -- | -- | -3,832.94 | -- | -7.82 | 0.6265 | -- | 48.42 | -- | 23.85 | -- | -0.376 | -- |
| Essex Bio-Technology Ltd | 1.73bn | 313.18m | 2.51bn | 1.43k | 8.02 | 1.10 | 6.76 | 1.44 | 0.5508 | 0.5508 | 3.05 | 4.01 | 0.5596 | 2.96 | 2.84 | 1,196,360.00 | 10.10 | 10.28 | 13.56 | 13.62 | 89.50 | 87.73 | 18.05 | 18.70 | 1.82 | -- | 0.1135 | 17.49 | -3.87 | 5.47 | 11.61 | 0.3101 | -7.47 | 7.14 |
| Jacobson Pharma Corporation Ltd | 1.53bn | 302.58m | 2.54bn | 1.79k | 8.36 | 1.14 | 5.63 | 1.66 | 0.1519 | 0.1519 | 0.7698 | 1.12 | 0.4299 | 2.54 | 9.06 | 876,757.00 | 8.48 | 4.83 | 10.29 | 6.17 | 44.30 | 41.26 | 19.73 | 14.85 | 0.9023 | 10.21 | 0.286 | 57.09 | 7.43 | 0.0691 | 43.09 | 7.05 | 24.09 | 14.87 |
Data as of Feb 13 2026. Currency figures normalised to JBM (Healthcare) Ltd's reporting currency: Hong Kong Dollar HKD
0.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 1.12m | 0.14% |
| WBS H�nicke Verm�gensverwaltung GmbHas of 31 Dec 2025 | 218.00k | 0.03% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 112.16k | 0.01% |
| DFA Australia Ltd.as of 31 Dec 2025 | 64.51k | 0.01% |
| American Century Investment Management, Inc.as of 08 Jan 2026 | 1.00k | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
